Delivery Order SPE2DB22D3004-SPE2DB23FRC85
Award Date 8/24/23
Potential Completion Date 8/25/23
Potential Value $2.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $6,590.28 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride 0.2% injection. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the analgesic medication from its facility in Conshohocken, Pennsylvania to support Defense Logistics Agency programs. No subcontractors or set aside designations were identified. The single day period of performance...
- The Defense Logistics Agency awarded a $432 delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility by September 15, 2023 in accordance with firm fixed price terms. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were identified. The Defense...
- The Defense Logistics Agency awarded a $7,619 delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. The single delivery order is for 200 ml of the specified product and will be fulfilled by August 8, 2023 out of Amerisourcebergen's facility in Conshohocken, Pennsylvania. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor for the DOD and...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $5,649 to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania by August 29, 2023 in support of the Defense Logistics Agency's medical supply chain requirements. No set aside provisions...
- The Defense Logistics Agency awarded a $5,803.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine 0.2% to be delivered to its Conshohocken, Pennsylvania facility by September 12, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform under the contract. The Defense Logistics Agency manages the Department of Defense's global supply chain and works to ensure medical supplies are...
- The Defense Logistics Agency awarded a $864 delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride injection 0.2%. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DOD and other federal agencies. Amerisourcebergen will deliver the injections from its facility in Conshohocken, Pennsylvania by August 18, 2023 under firm fixed pricing. No subcontractors or...
- The Defense Logistics Agency Troop Support Medical awarded a $451.50 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 150 mg/30 ml vials of ropivacaine hydrochloride injection 0.5%. As the prime contractor, Amerisourcebergen Drug will deliver the local anesthetic to its place of performance in Conshohocken, Pennsylvania within the one day period of August 29-30, 2023. The delivery order was placed against an existing DLA medical supply vehicle and no...
- The Defense Logistics Agency awarded a $4,324.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine 0.2% to be delivered by September 11, 2023. Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, will fulfill the order from its facility in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the Department of Defense's global logistics operations, including procuring pharmaceuticals to...
- The Defense Logistics Agency awarded a $2,004.51 firm fixed price delivery order to Amerisourcebergen Drug Corp for 400 mg/200 ml vials of ropivacaine hydrochloride 0.2% injection. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements by August 25, 2023. No subcontractors or set aside designations were identified. This order is likely in support of DLA's medical supply...
- The Defense Logistics Agency awarded a $5,869.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine 0.2% to be delivered by July 5, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will fulfill the order from its facility in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to ensure medical supplies are available to...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB23FRC85Delivery Order
The Defense Logistics Agency awarded a $2,280.05 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/100 ml vials of ropivacaine hydrochloride injection 0.2%. Performance will take place in Conshohocken, Pennsylvania over one day in late August 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order from its corporate office division. The delivery order was issued under an existing DLA contract vehicle, though details of the contract were not provided. No set aside designation or subcontracting arrangements were indicated. This order supports the DLA's medical supply chain responsibilities for the U.S. military healthcare system.
Generated 12/15/23, 7:03 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/24/23 |